Physician profile
Peter A Ankoh
NPI 1720044241
$661.79
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $43.37 · 2022: $134 · 2023: $13.44 · 2024: $22.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $133.55 | 2019-2020 | |
| Amgen INC. | $96.49 | 2019 | |
| Astellas Pharma US INC | $95.22 | 2019-2022 | |
| Glaxosmithkline, LLC. | $63.10 | 2019 | |
| Mannkind Corporation | $59.40 | 2022 | |
| Amarin Pharma, INC. | $53.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $45.39 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $32.69 | 2019-2020 | |
| Boston Scientific Corporation | $22.06 | 2024 | Watchman Flx |
| Novo Nordisk INC | $19.42 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.35 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $13.44 | 2023 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $13.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ankoh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.